Your search returned 2729 results.

Results
	2721.	Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study. [electronic resource] by Antonuzzo, Lorenzo Giommoni, Elisa Pastorelli, Davide Latiano, Tiziana Pavese, Ida Azzarello, Domenico Aieta, Michele Pastina, Ilaria Di Fabio, Francesca Bertolini, Alessandro Corsi, Domenico Cristiano Mogavero, Selene Angelini, Valentina Pazzagli, Mario Di Costanzo, Francesco Producer: 20160329 In: World journal of gastroenterology vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2722.	A comparison of patency and interventions in thigh versus Hemodialysis Reliable Outflow grafts for chronic hemodialysis vascular access. [electronic resource] by Brownie, Evan R Kensinger, Clark D Feurer, Irene D Moore, Derek E Shaffer, David Producer: 20170515 In: Journal of vascular surgery vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2723.	Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial. [electronic resource] by Waddell, Tom Chau, Ian Cunningham, David Gonzalez, David Okines, Alicia Frances Clare Frances, Alicia Okines, Clare Wotherspoon, Andrew Saffery, Claire Middleton, Gary Wadsley, Jonathan Ferry, David Mansoor, Wasat Crosby, Tom Coxon, Fareeda Smith, David Waters, Justin Iveson, Timothy Falk, Stephen Slater, Sarah Peckitt, Clare Barbachano, Yolanda Producer: 20130628 In: The Lancet. Oncology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2724.	Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial. [electronic resource] by Malka, David Cervera, Pascale Foulon, Stéphanie Trarbach, Tanja de la Fouchardière, Christelle Boucher, Eveline Fartoux, Laetitia Faivre, Sandrine Blanc, Jean-Frédéric Viret, Frédéric Assenat, Eric Seufferlein, Thomas Herrmann, Thomas Grenier, Julien Hammel, Pascal Dollinger, Matthias André, Thierry Hahn, Philipp Heinemann, Volker Rousseau, Vanessa Ducreux, Michel Pignon, Jean-Pierre Wendum, Dominique Rosmorduc, Olivier Greten, Tim F Producer: 20140909 In: The Lancet. Oncology vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2725.	Long-term effects of the multidisciplinary risk assessment and management program for patients with diabetes mellitus (RAMP-DM): a population-based cohort study. [electronic resource] by Jiao, Fangfang Fung, Colman Siu Cheung Wan, Yuk Fai McGhee, Sarah Morag Wong, Carlos King Ho Dai, Daisy Kwok, Ruby Lam, Cindy Lo Kuen Producer: 20160421 In: Cardiovascular diabetology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2726.	Efficacy and tolerability of the new autoinjected suspension of exenatide once weekly versus exenatide twice daily in patients with type 2 diabetes. [electronic resource] by Wysham, Carol H Rosenstock, Julio Vetter, Marion L Dong, Fang Öhman, Peter Iqbal, Nayyar Producer: 20180727 In: Diabetes, obesity & metabolism vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2727.	Effectiveness of the population-based Check your health preventive programme conducted in primary care with 4 years follow-up [the CORE trial]: study protocol for a randomised controlled trial. [electronic resource] by Maindal, Helle Terkildsen Støvring, Henrik Sandbaek, Annelli Producer: 20150528 In: Trials vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2728.	A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer. [electronic resource] by del Carmen, Marcela G Micha, John Small, Laurie Street, Daron G Londhe, Anil McGowan, Tracy Producer: 20121016 In: Gynecologic oncology vol. 126 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2729.	The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study. [electronic resource] by Finn, Richard S Crown, John P Lang, Istvan Boer, Katalin Bondarenko, Igor M Kulyk, Sergey O Ettl, Johannes Patel, Ravindranath Pinter, Tamas Schmidt, Marcus Shparyk, Yaroslav Thummala, Anu R Voytko, Nataliya L Fowst, Camilla Huang, Xin Kim, Sindy T Randolph, Sophia Slamon, Dennis J Producer: 20150401 In: The Lancet. Oncology vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)